December 2016 – The U.S. Food and Drug Administration (FDA) finalized its guidance intended for institutional review boards (IRBs), investigators, and sponsors engaged in (or responsible for) oversight of human subject research under the Department of Health and Human...
Pearl Pathways announces the hiring of Waylon Wright as a Marketing and Sales Associate serving to expand the company’s commercialization efforts. Wright brings a diverse set of skills to the Pearl team, with over four years of sales, management, and marketing...
America prides itself as a leader in technological innovation and medical research. Home to some of the largest and well respected cancer centers in the world, the U.S. has stood as the epicenter for cancer research for several decades. If the U.S. wishes to retain...
The European Medicines Agency (EMA) released a report on Tuesday that analyzed over 100 applications submitted for medicines in the fields of psychiatry or neurology between 1995 and 2014. In the report, EMA concludes that various challenges can arise in the...
Pearl Pathways is pleased to announce the hiring of Shawn Knopp, PhD as an Advisor serving medical device and biopharmaceutical life science companies. Knopp brings to Pearl Pathways over 15 years of experience in multi-disciplinary life science roles including...
